Neutrophil recognition of bacterial DNA and Toll-like receptor 9-dependent and -independent regulation of neutrophil function

Archivum Immunologiae et Therapiae Experimentalis

Volumn 56, Issue 1, 2008, Pages 41-53

  El Kebir, Driss ^a   József, Levente ^a   Filep, János G ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Apoptosis; Bacterial DNA; Inflammation; Neutrophils; Toll like receptor 9

Indexed keywords

ALPHA INTERFERON; AMYLOID A PROTEIN; BACTERIAL DNA; BAFILOMYCIN A1; C REACTIVE PROTEIN; CHEMOKINE; CHLOROQUINE; CPG OLIGODEOXYNUCLEOTIDE; DOUBLE STRANDED DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; PEROXYNITRITE; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CELL SURVIVAL; CYSTIC FIBROSIS; DNA SEQUENCE; FLOW CYTOMETRY; HUMAN; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; NEUTROPHIL; NONHUMAN; OXIDATION REDUCTION REACTION; PHAGOCYTOSIS; PNEUMONIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SIGNAL TRANSDUCTION; SPUTUM; WESTERN BLOTTING; ANIMAL; BACTERIAL INFECTION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; NEUTROPHIL CHEMOTAXIS; PATHOLOGY;

ANIMALS; APOPTOSIS; BACTERIAL INFECTIONS; CELL SURVIVAL; DNA, BACTERIAL; GENE EXPRESSION REGULATION; HUMANS; MICE; NEUTROPHIL ACTIVATION; NEUTROPHIL INFILTRATION; NEUTROPHILS; TOLL-LIKE RECEPTOR 9;

EID: 43049183674     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-008-0008-3     Document Type: Review

References (126)

1. Agren J., Thiemermann C., Foster S. J., Wang J. E. and Aasen A. O. (2006): Cytokine responses to CpG DNA in human leukocytes. Scand. J. Immunol., 64, 61-68.
2. Akhtar M., Watson J. L., Nazli A. and McKay D. M. (2003): Bacterial DNA evokes epithelial IL-8 production by a MAPK-dependent, NF-κB-independent pathway. FASEB J., 17, 1319-1321.
3. Akira S. (2003): Mammalian Toll-like receptors. Curr. Opin. Immunol., 15, 5-11.
4. Akira S. and Takeda K. (2004): Toll-like receptor signalling. Nat. Rev. Immunol., 4, 499-511.
5. Alvarez M. E., Fuxman Bass J. I., Gefner J. R., Fernandez Calotti P. X., Costas M., Coso O. M., Gamberale R., Vermeulen M.E., Salamone G., Martinez D., Tanos T. and Trevani A. S. (2006): Neutrophil signaling pathways activated by bacterial DNA stimulation. J. Immunol., 177, 4037-4046.
6. Baldus S., Heaschen C., Meinertz T., Zeiher A. M., Eiserich J. P., Munzel T., Simoons M. L. and Hamm C. W. (2003): Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation, 108, 1440-1445.
7. Barton G. M., Kagan J. C. and Medzhitov R. (2006): Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat. Immunol., 7, 49-56.
8. Bauer S., Kisching C. J., Hacker H., Redecke V., Hausmann S., Akira S., Wagner H. and Lipford G. B. (2001): Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. USA, 98, 9237-9242.
9. Bellocchio S., Moretti S., Perruccio K., Fallarino F., Bozza S., Montagnoli C., Mosci P., Lipford G. B., Pitzurra L. and Romani L. (2004): TLRs govern neutrophil activity in aspergillosis. J. Immunol., 173, 7406-7415.
10. Bennouna S., Sukhumavasi W. and Denkers E. Y. (2006): Toxoplasma gondii inhibits Toll-like receptor 4 ligand-induced mobilization of intracellular tumor necrosis factor alpha to the surface of mouse peritoneal neutrophils. Infect. Immun., 74, 4274-4281.
11. Beutler B. (2004): Inferences, questions and possibilities in Toll-like receptor signalling. Nature, 430, 257-263.
12. Bicknell S., van Eden S., Hayashi S., Hards J., English D. and Hogg J. C. (1994): A non-radioisotopic method for tracing neutrophils in vivo using 5′-bromo-2′-deoxyuridine. Am. J. Respir. Cell. Mol. Biol., 10, 16-23.
13. Bird A. P. (1986): CpG rich islands and the function of DNA methylation. Nature, 321, 209-213.
14. Bird A. P. (1987): CpG islands as gene markers in the vertebrate nucleus. Trends Genet., 3, 342-347.
15. Bjorkbacka H., Kunjathoor V. V., Moore K. J., Koehn S., Ordija C. M., Lee M. A., Means T., Halmen K., Luster A. D., Golenback D. T. and Freeman M. W. (2004): Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat. Med., 10, 416-421.
16. Brinkmann M. M., Spooner E., Hoebe K., Beutler B., Ploegh H. L. and Kim Y-M. (2007): The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J. Cell Biol., 177, 265-275.
17. Buffon A., Biasucci L. M., Liuzzo G., D'Onofrio G., Crea F. and Maseri A. (2002): Widespread coronary inflammation in unstable angina. N. Engl. J. Med., 347, 5-12.
18. Charmoy M., Megnekou R., Allenbach C., Zweifel C., Perez C., Monnat K., Breton M., Ronet C., Launois P. and Tacchini-Cottier F. (2007): Leishmania major induces distinct neutrophil phenotypes in mice that are resistant or susceptible to infection. J. Leukoc. Biol., 82, 288-299.
19. Chu W., Gong X., Li Z., Takabayashi K., Ouyang H., Chen Y., Lois A., Chen D. J., Li G. C., Karim M. and Raz E. (2000): DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA. Cell, 103, 909-918.
20. Cloutier A., Ear T., Borissevitch O., Larivée P. and McDonald P. P. (2003): Inflammatory cytokine expression is independent of the c-Jun N-terminal kinase/AP-1 signaling cascade in human neutrophils. J. Immunol., 171, 3751-3761.
21. Coban C., Ishii K.J., Kawai T., Hemmi H., Sato S., Uematzu S., Yamamoto M., Takeuchi O., Itagaki S., Kumar N., Horii T. and Akira S. (2005): Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med., 201, 19-25.
22. Colotta F., Re F., Polentarutti N., Sozzani S. and Mantovani A. (1992): Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood, 80, 2012-2020.
23. Cowdery J. S., Chase J. H., Yi A. K. and Krieg A. M. (1996): Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. J. Immunol., 156, 4570-4575.
24. Deng G. M., Nilsson I. M., Verdrengh M., Collins L. V. and Tarkowski A. (1999): Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat. Med., 5, 702-705.
25. Deng J. C., Moore T. A., Newstead M. W., Zeng X., Krieg A. M. and Standiford T. J. (2004): CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection. J. Immunol., 173, 5148-5155.
26. Edfeldt K., Swedenborg J., Hansson G. K. and Yan Z. O. (2002): Expression of Toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation, 105, 1158-1161.
27. El Kebir D., József L., Khreiss, T. and Filep J. G. (2006): Inhibition of K+ efflux prevents mitochondrial dysfunction, and suppresses caspase-3-, apoptosis-inducing factor-, and endonuclease G-mediated constitutive apoptosis in human neutrophils. Cell. Signal., 18, 2302-2313.
28. El Kebir D., József L., Pan W., Petasis N. A., Serhan C. N. and Filep J. G. (2007): Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation. J. Immunol., 179, 616-622.
29. Evans T. J., Buttery L. D. K., Carpenter A., Springall D. R., Polak J. M. and Cohen J. (1996): Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria. Proc. Natl. Acad. Sci. USA, 93, 9553-9558.
30. Filep J. G., Beauchamp M., Baron C. and Paquette Y. (1998): Peroxynitrite mediates IL-8 gene expression and production in lipopolysaccharide-stimulated human whole blood. J. Immunol., 161, 5656-5662.
31. Francois S., El Benna J., Dang P. M., Pedruzzi E., Gougerot-Pocidalo M.-E. and Elbim C. (2005): Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-κB signaling pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad. J. Immunol., 174, 3633-3642.
32. Freudenberg M. A. and Galanos C. (1991): Tumor necrosis factor alpha mediates lethal activity of killed Gram-negative and Gram-positive bacteria in D-galactosamine-treated mice. Infect. Immun., 59, 2110-2115.
33. Galinanes M. and Matata B. M. (2002): Protein nitration is predominantly mediated by peroxynitrite-dependent pathway in cultured human leukocytes. Biochem. J., 367, 467-473.
34. Garlichs C. D., Eskafi S., Cicha I., Schmeisser A., Walzog B., Raaz D., Stunpf C., Yilmaz A., Bremer J., Ludwig J. and Daniel W. G. (2004): Delay of neutrophil apoptosis in acute coronary syndromes. J. Leukoc. Biol., 75, 828-835.
35. Gilroy D. W., Lawrence T., Perretti M. and Rossi A. G. (2004): Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug Discov., 3, 401-416.
36. Gottlieb R. A., Giesing H. A., Zhu J. Y., Engler R. L. and Babior B. M. (1995): Cell acidification in apoptosis: granulocyte colony-stimulating factor delays programmed cell death in neutrophils by up-regulating the vacuolar H(+)-ATPase. Proc. Natl. Acad. Sci. USA, 92, 5965-5968.
37. Gursel I., Gursel M., Yamada H, Ishii K. J., Takeshita F. and Klinman D. M. (2003): Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation. J. Immunol., 171, 1393-1400.
38. Häcker G., Redecke V. and Häcker H. (2002): Activation of the immune system by bacterial CpG-DNA. Immunology, 105, 245-251.
39. Han J., Zhu Z., Hsu C. and Finley W. H. (1994): Selection of antisense oligonucleotides on the basis of genomic frequency of the target sequence. Antisense Res. Dev., 4, 53-65.
40. Hansson G. K. and Libby P. (2006): The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol., 6, 508-519.
41. Hartmann G. and Krieg A. M. (2000): Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J. Immunol., 164, 944-953.
42. Hayashi F., Means T. K. and Luster A. D. (2003): Toll-like receptors stimulate human neutrophil function. Blood, 102, 2660-2669.
43. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K. and Akira S. (2000): A Toll-like receptor recognizes bacterial DNA. Nature, 408, 740-745.
44. Hessel E. M., Chu M., Lizcano J. O., Chang B., Herman N., Kell S. A., Wills-Karp M. and Coffman R. L. (2005): Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction. J. Exp. Med., 202, 1563-1573.
45. Hoarau C., Gerard B., Lescanne E., Henry D., Francois S., Lacapere J. J., El Benna J., Dang P. M., Grandchamp B., Lebranchu Y., Gougerot-Pocidalo M. A. and Elbim C. (2007): TLR9 activation induces normal neutrophil responses in a child with IRAK-4 deficiency: involvement of the direct PI3K pathway. J. Immunol., 179, 4754-4765.
46. Huang X., Barrett R. P., McClellan S. A. and Hazlett L. D. (2005): Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci., 46, 4209-4216.
47. Ishii K. J. and Akira S. (2006): Innate immune recognition of, and regulation by, DNA. Trends Immunol., 27, 525-532.
48. Ishii K. J. Coban C., Kato H., Takahashi K., Torii Y., Takeshita F., Ludwig H., Sutter G., Suzuki K., Hemmi H., Sato S., Yamamoto M., Uematzu S., Takeuchi O. and Akira S. (2006): A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol., 7, 40-48.
49. Jack R. M. and Fearon D. T. (1988): Selective synthesis of mRNA and proteins by human peripheral blood neutrophils. J. Immunol., 140, 4286-4293.
50. Janeway C. A. Jr. and Medzhitov R. (2002): Innate immune recognition. Annu. Rev. Immunol., 20, 197-216.
51. Johnson A. C., Heinzel F. P., Diaconu E., Sun Y., Hise A. G., Golenbock D., Lass J. H. and Perlman E. (2005): Activation of toll-like receptor (TLR)2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation. Invest. Ophthalmol. Vis. Sci., 46, 589-595.
52. József L., Khreiss T., El Kebir D. and Filep J. G. (2006): Activation of TLR-9 induces IL-8 secretion through peroxynitrite signaling in human neutrophils. J. Immunol., 176, 1195-1202.
53. József L., Khreiss T. and Filep J. G. (2004): CpG motifs in bacterial DNA delay apoptosis of neutrophil granulocytes. FASEB J., 18, 1776-1778.
54. József L., Zouki C., Petasis N. A., Serhan C. N. and Filep J. G. (2002): Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-κB and AP-1 activation, and IL-8 gene expression in human leukocytes. Proc. Natl. Acad. Sci. USA, 99, 13266-13271.
55. Katakura K., Lee J., Rachmilewitz D., Li G., Eckmann L. and Raz E. (2005): Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J. Clin. Invest., 115, 695-702.
56. Keel M., Ungethum U. Steckholzer U., Niederer E., Hartung T., Trentz O. and Ertel W. (1997): Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during sepsis. Blood, 90, 3356-3363.
57. Khreiss T, József L., Hossain S., Potempa L. A. and Filep J. G. (2002): Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils. J. Biol. Chem., 277, 40775-40781.
58. Krieg A. M. (2002): CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol., 20, 709-760.
59. Krieg A. M. (2003): CpG motifs: the active ingredient in bacterial extracts? Nat. Med., 9, 831-835.
60. Krieg A. M. (2006): Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug Discov., 5, 471-484.
61. Krieg A. M., Yi A. K., Matson S., Waldschmidt T. J., Bishop G. A., Teasdale R., Koretzky G. A. and Klinman D. M. (1995): CpG motifs in bacterial DNA trigger direct B-cell activation. Nature, 374, 546-549.
62. Kol A., Lichtman A. H., Finberg R. W., Libby P. and Kurt-Jones E. A. (2000): Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J. Immunol., 164, 13-17.
63. Kroemer G. (1997): The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med., 3, 614-620.
64. Kurt-Jones E. A., Mandell L., Whitney C., Padgett A., Gosselin K., Newburger P. E. and Finberg R. W. (2002): Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood, 100, 1860-1868.
65. Latz E., Schoenemeyer A., Visintin A., Fitzgerald K. A., Monks B. G., Knetter C. F., Lien E., Nilsen N. J., Espevik T. and Golenbock D. T. (2004): TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol., 5, 190-198.
66. Lee A., Whyte M. K. and Haslett C. (1993): Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J. Leukoc. Biol., 54, 283-288.
67. Lehtiniemi J., Karhunen P. J., Goebeler S., Nikkari S. and Nikkari S. T. (2005): Identification of different bacterial DNAs in human coronary arteries. Eur. J. Clin. Invest., 35, 13-16.
68. Leifer C. A., Brooks J. C., Hoelzer K., Lopez J., Kennedy M. N., Mazzoni A. and Segal D. M. (2006): Cytoplasmic targeting motifs control localization of toll-like receptor 9. J. Biol. Chem., 281, 35585-35592.
69. Leifer C. A., Kennedy M. N., Mazzoni A., Lee C., Krublak M. J. and Segal D. M. (2004): TLR9 is localized in the endoplasmic reticulum prior to stimulation. J. Immunol., 173, 1179-1183.
70. Ley K., Laudanna C., Cybulsky M. I. and Noursargh S. (2007): Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol., 7, 678-689.
71. +-antiport. J. Biol. Chem., 270, 3203-3211.
72. Maianski N. A., Geissler J., Srinivasula S. M., Alnemri E. S., Roos D. and Kuijpers T. W. (2004): Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis. Cell Death Differ., 11, 143-153.
73. Maianski N. A., Mul F. P. J., van Buul J. D., Roos D. and Kuijpers T. W. (2002): Granulocyte colony-stimulating factor inhibits the mitochondria- dependent activation of caspase-3 in neutrophils. Blood, 99, 672-679.
74. Martin D. A. and Elkon K. B. (2006): Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a Toll-like receptor 9-independent pathway. Arthritis Rheum., 54, 951-962.
75. Matata B. M. and Galinanes M. (2002): Peroxynitrite is an essential component of cytokines production mechanism in human monocytes through modulation of nuclear factor-κB DNA binding activity. J. Biol. Chem., 277, 2330-2335.
76. Matute-Bello G., Liles W. C., Radella F., Steinberg K. P., Ruzinski J. T., Jonas M., Chi E. Y., Hudson L. D. and Martin T. R. (1997): Neutrophil apoptosis in the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med., 156, 1969-1977.
77. Michelsen K. S., Wong M. H., Shah P. K., Zhang W., Yano J., Doherty T. M., Akira S., Rajavashisth T. B. and Arditi M. (2004): Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl. Acad. Sci. USA, 101, 10679-10684.
78. Mukaida N., Mahe Y. and Matsushima K. (1990): Cooperative interaction of nuclear factor-κB- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J. Biol. Chem., 265, 21128-21133.
79. Mukaida N., Okamoto S., Ishikawa Y. and Matsushima K. (1994): Molecular mechanism of interleukin-8 gene expression. J. Leukoc. Biol., 56, 554-558.
80. Nagase H., Okugawa S., Ota Y., Yamaguchi M., Tomizawa H., Matsushima K., Ohta K., Yamamoto K. and Hirai K. (2003): Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J. Immunol., 171, 3977-3982.
81. Nathan C. (2002): Points of control of inflammation. Nature, 420, 846-852.
82. Obermeier F., Dunger N., Deml L., Herfarth H., Scholmerich J. and Falk W. (2002): CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate soidum-treated mice. Eur. J. Immunol., 32, 2084-2092.
83. Okabe Y., Kawane K., Akira S., Taniguchi T. and Nagata S. (2005): Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J. Exp. Med., 202, 1333-1339.
84. Parker L. C., Whyte M. K. B., Dower S. K. and Sabroe I. (2005): The expression and roles of Toll-like receptors in the biology of the human neutrophil. J. Leukoc. Biol., 77, 886-892.
85. Parroche P., Lauw F. N., Goutagny N., Latz E., Monks B. G., Visintin A., Halmen K. A., Lamphier M., Olivier M., Bartholomeu D. C., Gazzinelli R. T. and Golenbock D. T. (2007): Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc. Natl. Acad. Sci. USA, 104, 1919-1924.
86. Pelletier M., Ratthe C. and Girard D. (2002): Mechanisms involved in interleukin-15-induced suppression of human neutrophil apoptosis: role of the anti-apoptotic Mcl-1 protein and several kinases including Janus kinase-2, p38 mitogen-activated protein kinase and extracellular signal-regulated kinases-1/2. FEBS Lett., 532, 164-170.
87. Rachmilewitz D., Katakura K., Karmeli F., Hayashi T., Reinus C., Rudensky B., Akira S., Takeda K., Lee J., Takabayashi K. and Raz E. (2004): Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology, 126, 520-528.
88. Radsak M. P., Shalih H. R., Rammensee H. G. and Schild H. (2004): Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival. J. Immunol., 172, 4956-4963.
89. Ratanarat R., Cazzavillan S., Ricci Z., Rassu M., Segala C., de Cal M., Cruz D., Corradi V., Manfro S., Roessler E., Levin N. and Ronco C. (2007): Usefulness of a molecular strategy for the detection of bacterial DNA in patients with severe sepsis undergoing continuous renal replacement therapy. Blood Purif., 25, 106-111.
90. Reed J. C. (1997): Double identity for proteins of the Bcl-2 family. Nature, 387, 773-776.
91. Reed J. C. (2006): Proapoptotic multidomain Bcl-2/Bax family proteins: mechanisms, physiological roles and therapeutic opportunities. Cell Death Differ., 13, 1378-1386.
92. Roberts T. L., Dunn J. A., Terry T. D., Jennings M. P., Hume D. A., Sweet M. J. and Stacey K. J. (2005): Differences in macrophage activation by bacterial DNA and CpG-containing oligonucleotides. J. Immunol., 175, 3569-3576.
93. Romani L. (2004): Immunity to fungal infections. Nat. Rev. Immunol., 4, 1-23.
94. Ronaghy A., Prakken B. J., Takabayashi K., Firestein G. S., Boyle D., Zvailfler N. J., Roord S. T., Albani S., Carson D. A. and Raz E. (2002): Immunostimulatory DNA sequences influence the course of adjuvant arthritis. J. Immunol., 168, 51-56.
95. Rutz M., Metzger ., Gellert T., Luppa P., Lipford G. B., Wagner H. and Bauer S. (2004): Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur. J. Immunol., 34, 2541-2550.
96. Sabroe I., Prince L. R., Dower S. K., Walmsley S. R., Chilvers E. R. and Whyte M. K. (2004): What can we learn from highly purified neutrophils? Biochem. Soc. Trans., 32, 468-469.
97. Sabroe I., Prince L. R., Jones F. C., Horsburgh M. J., Foster S. J., Vogel S. N., Dower S. K. and Whyte M. K. (2003): Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. J. Immunol., 170, 5268-5275.
98. Savill J., Dransfield I., Gregory C. and Haslett C. (2002): A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol., 2, 965-975.
99. Savill J., Dransfield I., Hogg N. and Haslett C. (1990): Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature, 343, 170-173.
100. Savill J. S., Wyllie A. H., Henson J. E., Walport M. J., Henson P. M. and Haslett J. C. (1989): Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest., 83, 865-875.
101. 4. FEBS Lett., 244, 357-360.
102. Schwartz D. A., Quinn T. J., Thorne P. S., Sayeed S., Yi A. K. and Krieg A. M. (1997): CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. J. Clin. Invest., 100, 68-73.
103. Serhan C. N., Brain S. D., Buckley C. D., Gilroy D. W., Haslett C., O'Neill L. A. J., Perretti M., Rossi A. G. and Wallace J. L. (2007): Resolution of inflammation: state of the art, definitions and terms. FASEB J., 21, 325-332.
104. Serhan C. N. and Savill J. (2005): Resolution of inflammation: the beginning programs the end. Nat. Immunol., 6, 1199-1205.
105. Simon H. U. (2003): Neutrophil apoptosis pathways and their modifications in inflammation. Immunol. Rev., 193, 101-110.
106. Sparwasser T., Miethke T., Lipford G., Borschert K., Hacker H., Heeg K. and Wagner H. (1997): Bacterial DNA causes septic shock. Nature, 386, 336-337.
107. Stetson D. B. and Medzhitov R. (2006): Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity, 24, 93-103.
108. Tabeta K., Hoebe K., Janssen E. M., Du X., Georgel P., Crozat K., Mudd S., Mann N., Sovath S., Goode J., Shamel L., Herskovits A. A., Portnoy D. A., Cooke M., Tarantino L. M., Wiltshire T., Steinberg B. E., Grinstein S. and Beutler B. (2006): The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat. Immunol., 7, 156-164.
109. Takaoka A., Wang Z. C., Choi M. K., Yanai H., Negishi H., Ban T., Lu Y., Miyagashi M., Kodama T., Honda K., Ohba Y. and Taniguchi T. (2007): DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature, 448, 501-505.
110. Trevani A. S., Chorny A., Salamone G., Vermeulen M., Gamberale R., Schettini J., Raiden S. and Geffner J. (2003): Bacterial DNA activates human neutrophils by a CpG-independent pathway. Eur. J. Immunol., 33, 3164-3174.
111. Underhill D. M., Ozinsky A., Hajjar A. M., Stevens A., Wislon C.D., Bassetti, M. and Aderem A. (1999): The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature, 401, 811-815.
112. Wallerath T., Gath I., Aulitzky W. E., Pollock J. S., Kleinert H. and Förstermann U. (1997): Identification of the NO synthase isoforms expressed in human neutrophil granulocytes, megakaryocytes and platelets. Thromb. Haemost., 77, 163-167.
113. Weighardt H., Feterowski C., Veit M., Rump M., Wagner H. and Holzmann B. (2000): Increased resistance against acute polymicrobial sepsis in mice challenged with immunostimulatory CpG oligodeoxynucleotides is related to an enhanced innate effector cell response. J. Immunol., 165, 4537-4543.
114. Weiss S. J. (1989): Tissue destruction by neutrophils. N. Engl. J. Med., 320, 365-375.
115. Wheeler M. A., Smith S.D., Garcia-Cardena G., Nathan C. F., Weiss R. M. and Sessa W. C. (1997): Bacterial infection induces nitric oxide synthase in human neutrophils. J. Clin. Invest., 99, 110-116.
116. Whyte M. K., Meagher L. C., Macdermot J. and Haslett J. C. (1993): Impairment of function in aging neutrophils is associated with apoptosis. J. Immunol., 150, 5124-5134.
117. Wu H.-J., Sawaya H., Binstadt B., Brickelmaier M., Blasius A., Gorelik L., Mahmood U., Weissleder R., Carulli J., Benoist C. and Mathis D. (2007): Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross talk. J. Exp. Med., 204, 1911-1922.
118. Wuest T., Austin B. A., Uematsu S., Thapa M., Akira S. and Carr D. J.(2006): Intact TRL 9 and type I interferon signaling pathways are required to augment HSV-1 induced corneal CXCL9 and CXCL10. J. Neuroimmunol., 179, 46-52.
119. Xu X. H., Shah P. K., Faure E., Equils O., Thomas L., Fishbein M. C., Luthringer D., Xu X. P., Rajavashisth T. B., Yano J., Kaul S. and Arditi M. (2001): Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation, 104, 3103-3108
120. Yasuda K. Ogawa Y., Yamane I., Mishikawa M. and Takakura Y. (2005): Macrophage activation by a DNA/cationic liposome complex requires endosomal acidification and TLR9-dependent and -independent pathways. J. Leukoc. Biol., 77, 71-79.
121. Yasuda K., Yu P., Kirschning C. J., Schlatter D., Schmitz F., Heit A., Bauer S., Hochrein H. and Wagner H. (2005): Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways. J. Immunol., 174, 6129-6136.
122. Yi A. K., Tuetken R., Redford T., Waldschmidt M., Kirsch J. and Krieg A. M. (1998): CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species. J. Immunol., 160, 4755-4761.
123. Yi A. K., Yoon H., Park J. E., Kim B. S., Kim H. J. and Martinez-Hernandez A. (2006): CpG DNA-mediated induction of acute liver injury in D-galactosamine-sensitized mice: the mitochondrial apoptotic pathway-dependent death of hepatocytes. J. Biol. Chem., 281, 15001-15012.
124. +-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J. Biol. Chem., 266, 17707-17712.
125. Zamzami N., Marchetti P., Castedo M., Zanin C., Vayssiere J. L., Petit P. X. and Kroemer G. (1995): Reduction of mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med., 181, 1661-1672.
126. Zouki C., József L., Ouellet S., Paquette Y. and Filep J. G. (2001): Peroxynitrite mediates cytokine-induced IL-8 gene expression and production by human leukocytes. J. Leukoc. Biol., 69, 815-824.